Boston Collaborative Drug Surveillance Program

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

No new safety signals for apremilast (Otezla) identified in 5-year prospective study of psoriasis / PsA patients in UK @CPRD @DrugSafetyJ #MedTwitter #DermTwitter #RheumTwitter @rspersson https://t.co/dSfHB7UpeS

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

Indication for use is reliably captured in @CPRD Aurum for BPH drugs with multiple indications; study results informative for medical research where knowing indication is important @ClinEpidem #EpiTwitter @rspersson https://t.co/sAQkBba4N4

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

No new safety signals for apremilast (Otezla) identified in 5-year prospective study of psoriasis / PsA patients in UK @CPRD @DrugSafetyJ #MedTwitter #DermTwitter #RheumTwitter @rspersson

https://t.co/dSfHB7TRpk

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

Diclofenac was associated with increased MI risk. For other NSAIDs, the association with MI may be in part explained by reverse causality bias @brendabaak @CPRD #EpiTwitter #MedTwitter https://t.co/slhRLXxRBK

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

Heavy menstrual bleed and hysterectomy were more common with VWD, highlighting substantial impact during key fertility/conception years J Womens Health @hagbergkw https://t.co/oKhw6KhN6l @CPRD #EpiTwitter #Hemetwitter #MedTwitter #gyntwitter

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

https://t.co/4AIItw1bBO

[Boston Collaborative Drug Surveillance Program @BCDSP_DRG]

“The risk of venous thromboembolism (VTE) in men with benign prostatic hyperplasia treated with 5-Alpha Reductase Inhibitors (5ARIs)” published in @ClinEpidem (@DovePress) by Dr. @LadeEpi
#PhDpaper #PhDResearch @CPRD #5ARI #VTE #EpiTwitter #FreePDFofFullArticle